Cargando…
The FDA-Approved Anti-Asthma Medicine Ciclesonide Inhibits Lung Cancer Stem Cells through Hedgehog Signaling-Mediated SOX2 Regulation
Ciclesonide is an FDA-approved glucocorticoid (GC) used to treat asthma and allergic rhinitis. However, its effects on cancer and cancer stem cells (CSCs) are unknown. Our study focuses on investigating the inhibitory effect of ciclesonide on lung cancer and CSCs and its underlying mechanism. In thi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038186/ https://www.ncbi.nlm.nih.gov/pubmed/32033067 http://dx.doi.org/10.3390/ijms21031014 |
_version_ | 1783500595580108800 |
---|---|
author | Choi, Hack Sun Kim, Su-Lim Kim, Ji-Hyang Lee, Dong-Sun |
author_facet | Choi, Hack Sun Kim, Su-Lim Kim, Ji-Hyang Lee, Dong-Sun |
author_sort | Choi, Hack Sun |
collection | PubMed |
description | Ciclesonide is an FDA-approved glucocorticoid (GC) used to treat asthma and allergic rhinitis. However, its effects on cancer and cancer stem cells (CSCs) are unknown. Our study focuses on investigating the inhibitory effect of ciclesonide on lung cancer and CSCs and its underlying mechanism. In this study, we showed that ciclesonide inhibits the proliferation of lung cancer cells and the growth of CSCs. Similar glucocorticoids, such as dexamethasone and prednisone, do not inhibit CSC formation. We show that ciclesonide is important for CSC formation through the Hedgehog signaling pathway. Ciclesonide reduces the protein levels of GL1, GL2, and Smoothened (SMO), and a small interfering RNA (siRNA) targeting SMO inhibits tumorsphere formation. Additionally, ciclesonide reduces the transcript and protein levels of SOX2, and an siRNA targeting SOX2 inhibits tumorsphere formation. To regulate breast CSC formation, ciclesonide regulates GL1, GL2, SMO, and SOX2. Our results unveil a novel mechanism involving Hedgehog signaling and SOX2 regulated by ciclesonide in lung CSCs, and also open up the possibility of targeting Hedgehog signaling and SOX2 to prevent lung CSC formation. |
format | Online Article Text |
id | pubmed-7038186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70381862020-03-10 The FDA-Approved Anti-Asthma Medicine Ciclesonide Inhibits Lung Cancer Stem Cells through Hedgehog Signaling-Mediated SOX2 Regulation Choi, Hack Sun Kim, Su-Lim Kim, Ji-Hyang Lee, Dong-Sun Int J Mol Sci Article Ciclesonide is an FDA-approved glucocorticoid (GC) used to treat asthma and allergic rhinitis. However, its effects on cancer and cancer stem cells (CSCs) are unknown. Our study focuses on investigating the inhibitory effect of ciclesonide on lung cancer and CSCs and its underlying mechanism. In this study, we showed that ciclesonide inhibits the proliferation of lung cancer cells and the growth of CSCs. Similar glucocorticoids, such as dexamethasone and prednisone, do not inhibit CSC formation. We show that ciclesonide is important for CSC formation through the Hedgehog signaling pathway. Ciclesonide reduces the protein levels of GL1, GL2, and Smoothened (SMO), and a small interfering RNA (siRNA) targeting SMO inhibits tumorsphere formation. Additionally, ciclesonide reduces the transcript and protein levels of SOX2, and an siRNA targeting SOX2 inhibits tumorsphere formation. To regulate breast CSC formation, ciclesonide regulates GL1, GL2, SMO, and SOX2. Our results unveil a novel mechanism involving Hedgehog signaling and SOX2 regulated by ciclesonide in lung CSCs, and also open up the possibility of targeting Hedgehog signaling and SOX2 to prevent lung CSC formation. MDPI 2020-02-04 /pmc/articles/PMC7038186/ /pubmed/32033067 http://dx.doi.org/10.3390/ijms21031014 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Choi, Hack Sun Kim, Su-Lim Kim, Ji-Hyang Lee, Dong-Sun The FDA-Approved Anti-Asthma Medicine Ciclesonide Inhibits Lung Cancer Stem Cells through Hedgehog Signaling-Mediated SOX2 Regulation |
title | The FDA-Approved Anti-Asthma Medicine Ciclesonide Inhibits Lung Cancer Stem Cells through Hedgehog Signaling-Mediated SOX2 Regulation |
title_full | The FDA-Approved Anti-Asthma Medicine Ciclesonide Inhibits Lung Cancer Stem Cells through Hedgehog Signaling-Mediated SOX2 Regulation |
title_fullStr | The FDA-Approved Anti-Asthma Medicine Ciclesonide Inhibits Lung Cancer Stem Cells through Hedgehog Signaling-Mediated SOX2 Regulation |
title_full_unstemmed | The FDA-Approved Anti-Asthma Medicine Ciclesonide Inhibits Lung Cancer Stem Cells through Hedgehog Signaling-Mediated SOX2 Regulation |
title_short | The FDA-Approved Anti-Asthma Medicine Ciclesonide Inhibits Lung Cancer Stem Cells through Hedgehog Signaling-Mediated SOX2 Regulation |
title_sort | fda-approved anti-asthma medicine ciclesonide inhibits lung cancer stem cells through hedgehog signaling-mediated sox2 regulation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038186/ https://www.ncbi.nlm.nih.gov/pubmed/32033067 http://dx.doi.org/10.3390/ijms21031014 |
work_keys_str_mv | AT choihacksun thefdaapprovedantiasthmamedicineciclesonideinhibitslungcancerstemcellsthroughhedgehogsignalingmediatedsox2regulation AT kimsulim thefdaapprovedantiasthmamedicineciclesonideinhibitslungcancerstemcellsthroughhedgehogsignalingmediatedsox2regulation AT kimjihyang thefdaapprovedantiasthmamedicineciclesonideinhibitslungcancerstemcellsthroughhedgehogsignalingmediatedsox2regulation AT leedongsun thefdaapprovedantiasthmamedicineciclesonideinhibitslungcancerstemcellsthroughhedgehogsignalingmediatedsox2regulation AT choihacksun fdaapprovedantiasthmamedicineciclesonideinhibitslungcancerstemcellsthroughhedgehogsignalingmediatedsox2regulation AT kimsulim fdaapprovedantiasthmamedicineciclesonideinhibitslungcancerstemcellsthroughhedgehogsignalingmediatedsox2regulation AT kimjihyang fdaapprovedantiasthmamedicineciclesonideinhibitslungcancerstemcellsthroughhedgehogsignalingmediatedsox2regulation AT leedongsun fdaapprovedantiasthmamedicineciclesonideinhibitslungcancerstemcellsthroughhedgehogsignalingmediatedsox2regulation |